However, conflicting results emerged on the relationship between the pattern of Gal-3 expression and tumor progression because some studies reported decreased or comparable Gal-3 levels during CRC progression [53,54,55,56,57,58,59]. The gene discussed is LGALS3; the disease is colorectal carcinoma.